VRC01 in Acutely Treated HIV-infected Adults: A Randomised, Double-blind, Placebo-controlled Trial

BACKGROUND: HIV-1-specific broadly neutralizing antibodies such as VRC01 could promote HIV remission by halting viral replication and clearing infected cells. We conducted a randomised, double-blinded, placebo-controlled trial of VRC01 in adults who initiated antiretroviral therapy (ART) during acut...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet HIV
Main Authors: Crowell, Trevor A., Colby, Donn J., Pinyakorn, Suteeraporn, Sacdalan, Carlo, Pagliuzza, Amélie, Intasan, Jintana, Benjapornpong, Khunthalee, Tangnaree, Kamonkan, Chomchey, Nitiya, Kroon, Eugène, de Souza, Mark S., Tovanabutra, Sodsai, Rolland, Morgane, Eller, Michael A., Paquin-Proulx, Dominic, Bolton, Diane L., Tokarev, Andrey, Thomas, Rasmi, Takata, Hiroshi, Trautmann, Lydie, Krebs, Shelly J., Modjarrad, Kayvon, McDermott, Adrian B., Bailer, Robert T., Doria-Rose, Nicole, Patel, Bijal, Gorelick, Robert J., Fullmer, Brandie A, Schuetz, Alexandra, Grandin, Pornsuk V., O’Connell, Robert J., Ledgerwood, Julie E., Graham, Barney S., Tressler, Randall, Mascola, John R., Chomont, Nicolas, Michael, Nelson L., Robb, Merlin L., Phanuphak, Nittaya, Ananworanich, Jintanat
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693657/
https://ncbi.nlm.nih.gov/pubmed/31000477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3018(19)30053-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados